Increasing investment in interventional cardiology infrastructure is supporting the Atherectomy Devices Market. Hospitals are expanding catheterization laboratories and acquiring advanced imaging and vascular treatment equipment to manage complex cardiovascular conditions.

The atherectomy devices market size was valued at US$ 1.08 billion in 2025 and is projected to reach US$ 1.96 billion by 2034, expanding at a CAGR of 6.85% during 2026–2034. Market growth is driven by the increasing prevalence of peripheral artery disease (PAD), rising demand for minimally invasive vascular procedures, and advancements in catheter-based treatment technologies. Atherectomy devices are used to remove or modify plaque buildup inside arteries, helping restore blood flow and support the treatment of complex vascular conditions. Growing adoption of endovascular procedures and improvements in image-guided interventions are further supporting market development.

What Is Driving the Atherectomy Devices Market?

The increasing prevalence of peripheral artery disease is a major factor driving demand for atherectomy devices. PAD is commonly associated with atherosclerosis, in which plaque accumulates inside arteries and restricts blood circulation. Aging populations, diabetes, smoking, obesity, and cardiovascular risk factors contribute to the growing burden of vascular disease. As diagnosis and treatment rates increase, healthcare providers are seeking effective technologies to manage complex arterial blockages.

Get a Sample PDF- https://www.theinsightpartners.com/sample/TIPHE100001272

The growing preference for minimally invasive vascular procedures is another important growth driver. Atherectomy allows physicians to remove or modify plaque through catheter-based techniques rather than relying exclusively on open surgical approaches. These procedures can support blood vessel preparation and may improve treatment options for patients with heavily calcified or complex lesions.

Technological advancements are also contributing to market expansion. Manufacturers are developing devices with improved navigation, plaque removal capabilities, and procedural control. Integration with imaging technologies and advances in catheter design are helping physicians perform more targeted interventions. Increasing investment in cardiovascular care infrastructure is further supporting adoption.

Which Region Leads the Atherectomy Devices Market?

North America represents an important market for atherectomy devices due to its established cardiovascular healthcare infrastructure, availability of advanced interventional technologies, and growing adoption of minimally invasive vascular procedures. The presence of major medical device manufacturers and specialized treatment centers also supports regional market development.

Europe is another significant market, supported by established healthcare systems, specialist vascular care facilities, and increasing use of endovascular procedures. Meanwhile, Asia-Pacific offers considerable growth potential as healthcare infrastructure expands and awareness of peripheral artery disease improves. Rising healthcare expenditure, a growing elderly population, and increasing access to advanced cardiovascular treatments are creating opportunities in countries such as China, India, and Japan. The specific leading region is not identified in the supplied market data.

Which Segments Shape the Atherectomy Devices Market?

The atherectomy devices market includes different technologies designed to remove, modify, or reduce arterial plaque. Major device categories include directional atherectomy, rotational atherectomy, orbital atherectomy, and laser atherectomy. Each technology uses a different mechanism to address plaque buildup and is selected according to lesion characteristics, vessel anatomy, and physician preference.

Directional atherectomy devices remove targeted plaque from the arterial wall, while rotational and orbital systems use specialized mechanisms to modify calcified or obstructive material. Laser atherectomy uses laser energy to break down plaque and other obstructive tissue. These technologies support treatment across different peripheral vascular conditions.

Hospitals, specialty cardiovascular centers, and ambulatory surgical facilities are important end users. The adoption of specific devices depends on procedural requirements, clinical outcomes, equipment costs, physician expertise, and compatibility with existing interventional systems.

Which Companies Are Prominent in the Atherectomy Devices Market?

The key companies analyzed in the report include:

B. Braun Melsungen AG
Koninklijke Philips N.V.
Cardinal Health
Medtronic
Terumo Corporation
C. R. Bard, Inc.
Minnetronix, Inc.
Avinger
Straub Medical AG
Biomerics
Abbott
RA Medical Systems
Boston Scientific Corporation

These companies participate in the market through vascular intervention technologies, catheter-based treatment systems, medical device manufacturing, and product development. Competition is influenced by device safety, plaque removal performance, procedural precision, clinical evidence, physician familiarity, and distribution capabilities.

What Is Changing in the Atherectomy Devices Market in 2026?

The market is increasingly influenced by advancements in endovascular treatment technologies and the growing emphasis on precision during vascular interventions. Manufacturers are focusing on improving device navigation, plaque modification, and compatibility with imaging-guided procedures. These improvements can help physicians address complex lesions and select suitable treatment approaches.

Another important development is the increasing focus on treating calcified arterial disease. Complex plaque characteristics can make vascular interventions more challenging, creating demand for specialized devices that support vessel preparation. Improvements in catheter engineering and procedural planning are contributing to the evolution of atherectomy technologies.

What Are the Major Investment Opportunities in the Atherectomy Devices Market?

Investment opportunities are emerging in advanced plaque removal technologies, catheter engineering, and imaging-compatible intervention systems. Companies can focus on developing devices that improve procedural control, support complex lesion treatment, and offer reliable performance across different vascular applications.

Emerging markets also provide opportunities as hospitals expand cardiovascular treatment capabilities and access to minimally invasive procedures improves. Strategic partnerships with healthcare providers, physician training initiatives, and broader distribution networks can support market penetration. Investment in research and development, clinical evidence, and product innovation may help manufacturers strengthen their competitive positions.

What Is the Future Outlook for the Atherectomy Devices Market Through 2034?

The atherectomy devices market is expected to maintain steady growth through 2034, increasing from US$ 1.08 billion in 2025 to US$ 1.96 billion by 2034, at a CAGR of 6.85%. Rising prevalence of peripheral artery disease, growing demand for minimally invasive vascular interventions, and technological improvements are expected to remain important market drivers.

The future market will be shaped by innovations in plaque modification technologies, improved catheter systems, and wider adoption of endovascular procedures. Companies that prioritize device reliability, procedural precision, clinical performance, and access to expanding healthcare markets will be positioned to address evolving vascular treatment requirements.

Related Reports:

Peripheral Artery Revascularisation Market Demand, Size & Forecast by 2034

Coronary Artery Disease Therapeutics Market Size, Share & Trends by 2034

About Us

The Insight Partners is a leading market research and consulting firm delivering actionable insights through in-depth industry analysis and strategic intelligence. The firm supports clients across various industries in making informed business decisions by providing comprehensive market forecasts, competitive assessments, and growth opportunities.

Contact Us

The Insight Partners

Email: sales@theinsightpartners.com

Phone: +1-646-491-9876

Website: www.theinsightpartners.com

Also Available in: Korean German Japanese French Chinese Italian Spanish

Atherectomy Devices Market Outlook 2034: Advancements in Minimally Invasive Vascular Treatments

Atherectomy Devices Market